Point-of-service outcomes data and its effect on asthma treatment: a salmeterol pilot investigation.
Outcomes data have enabled physicians to have a much more complete overview of the patient's quality of life and health than their predecessors. One medical center has sought to develop a comprehensive point-of-service outcomes measurement tool for the assessment of patients with asthma. This information may provide a real-time overview on a desktop computer system of the patient's progress. A pilot project involving a therapeutic intervention in patients with asthma was conducted to test the utility of this outcomes tool in a practice setting.
Bukstein
D
D
Mackowiak
J
J
D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006801:Humans; D017063:Outcome Assessment, Health Care; D010817:Physician-Patient Relations; D010865:Pilot Projects; D010818:Practice Patterns, Physicians' / Q000592:standards; D011243:Preferred Provider Organizations / Q000592:standards*; D011787:Quality of Health Care; D011788:Quality of Life; D012017:Referral and Consultation / Q000191:economics / Q000592:standards*; D000068299:Salmeterol Xinafoate; D011795:Surveys and Questionnaires; D014481:United States